Showing 1 to 12 of 17 results
Pfizer Publishes Covid-19 Vaccine Data Following Trump's Call for Transparency
Responding to President Trump's request, Pfizer released over 200 news releases, 27 peer-reviewed publications, and pledged more data on its Covid-19 vaccine's impact, highlighting its role in saving millions of lives and boosting the economy.
Pfizer Publishes Covid-19 Vaccine Data Following Trump's Call for Transparency
Responding to President Trump's request, Pfizer released over 200 news releases, 27 peer-reviewed publications, and pledged more data on its Covid-19 vaccine's impact, highlighting its role in saving millions of lives and boosting the economy.
Progress
36% Bias Score
US Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled almost $500 million in contracts for mRNA vaccine development, a decision that has alarmed public health experts who warn of increased vulnerability to future pandemics and bioterrorism; the justification cites safety and effectiveness concerns, w...
US Cancels $500 Million in mRNA Vaccine Contracts
The Department of Health and Human Services canceled almost $500 million in contracts for mRNA vaccine development, a decision that has alarmed public health experts who warn of increased vulnerability to future pandemics and bioterrorism; the justification cites safety and effectiveness concerns, w...
Progress
48% Bias Score
HHS Ends Funding for 22 mRNA Vaccine Projects
The US Department of Health and Human Services announced it is ending funding for 22 mRNA vaccine development projects, totaling approximately $500 million, citing concerns about safety and transparency, despite evidence of their effectiveness against severe COVID-19.
HHS Ends Funding for 22 mRNA Vaccine Projects
The US Department of Health and Human Services announced it is ending funding for 22 mRNA vaccine development projects, totaling approximately $500 million, citing concerns about safety and transparency, despite evidence of their effectiveness against severe COVID-19.
Progress
64% Bias Score
HHS Terminates Moderna Bird Flu Vaccine Contract
The US Department of Health and Human Services terminated a $590 million contract with Moderna to develop an mRNA-based bird flu vaccine due to safety and ethical concerns, despite Moderna's positive trial results, leaving the future of the project uncertain and raising concerns about pandemic prepa...
HHS Terminates Moderna Bird Flu Vaccine Contract
The US Department of Health and Human Services terminated a $590 million contract with Moderna to develop an mRNA-based bird flu vaccine due to safety and ethical concerns, despite Moderna's positive trial results, leaving the future of the project uncertain and raising concerns about pandemic prepa...
Progress
56% Bias Score
U.S. Cancels $766M Bird Flu Vaccine Contract, Raising Pandemic Preparedness Concerns
The U.S. government cancelled a $766 million contract with Moderna for an mRNA H5N1 bird flu vaccine due to safety concerns, prompting criticism from experts who warn of reduced pandemic preparedness.
U.S. Cancels $766M Bird Flu Vaccine Contract, Raising Pandemic Preparedness Concerns
The U.S. government cancelled a $766 million contract with Moderna for an mRNA H5N1 bird flu vaccine due to safety concerns, prompting criticism from experts who warn of reduced pandemic preparedness.
Progress
60% Bias Score
Moderna Stock Surges on Patent Win, but Weak Financials Raise Concerns
Moderna's stock jumped 16% after winning a patent infringement case against BioNTech and Pfizer, but its weak recent financial performance, including a 66% quarterly revenue drop and negative operating margins, raises concerns for investors despite a strong balance sheet.
Moderna Stock Surges on Patent Win, but Weak Financials Raise Concerns
Moderna's stock jumped 16% after winning a patent infringement case against BioNTech and Pfizer, but its weak recent financial performance, including a 66% quarterly revenue drop and negative operating margins, raises concerns for investors despite a strong balance sheet.
Progress
60% Bias Score
US Funding Cut Threatens mRNA Vaccine Development
The US government's recent cut in public funding for mRNA vaccine research, development, and production will hinder the development of innovative disease-fighting tools, leaving the global community less prepared for future pandemics and undermining public trust in science and medicine.
US Funding Cut Threatens mRNA Vaccine Development
The US government's recent cut in public funding for mRNA vaccine research, development, and production will hinder the development of innovative disease-fighting tools, leaving the global community less prepared for future pandemics and undermining public trust in science and medicine.
Progress
48% Bias Score
US Halts $500 Million in mRNA Vaccine Projects
The U.S. Department of Health announced on August 5th the termination of roughly 20 mRNA vaccine projects worth approximately $500 million, citing a shift in vaccine development priorities towards safer, broader alternatives despite criticism from experts who deem the decision risky, citing the tech...
US Halts $500 Million in mRNA Vaccine Projects
The U.S. Department of Health announced on August 5th the termination of roughly 20 mRNA vaccine projects worth approximately $500 million, citing a shift in vaccine development priorities towards safer, broader alternatives despite criticism from experts who deem the decision risky, citing the tech...
Progress
56% Bias Score
Australia Develops World-First mRNA Vaccine to Protect \$80 Billion Beef Industry
NSW scientists created a world-first mRNA vaccine protecting cows from foot-and-mouth disease, costing \$2.5 million, unlike conventional vaccines that risk accidental outbreaks; this safeguards Australia's \$80 billion beef export industry, with potential rollout within a week of an outbreak.
Australia Develops World-First mRNA Vaccine to Protect \$80 Billion Beef Industry
NSW scientists created a world-first mRNA vaccine protecting cows from foot-and-mouth disease, costing \$2.5 million, unlike conventional vaccines that risk accidental outbreaks; this safeguards Australia's \$80 billion beef export industry, with potential rollout within a week of an outbreak.
Progress
48% Bias Score
Trump Administration Terminates $750 Million in Funding for Moderna's mRNA Bird Flu Vaccine
The Trump administration terminated over $750 million in funding for Moderna's mRNA bird flu vaccine development, citing safety and ethical concerns, following previous funding from the Biden administration totaling $766 million; this reflects a broader policy shift prioritizing older populations an...
Trump Administration Terminates $750 Million in Funding for Moderna's mRNA Bird Flu Vaccine
The Trump administration terminated over $750 million in funding for Moderna's mRNA bird flu vaccine development, citing safety and ethical concerns, following previous funding from the Biden administration totaling $766 million; this reflects a broader policy shift prioritizing older populations an...
Progress
64% Bias Score
FDA Expands COVID-19 Vaccine Warnings for Myocarditis Risk in Young Men
The FDA is expanding warning labels on Pfizer and Moderna's COVID-19 vaccines to include a higher risk of myocarditis and pericarditis in males aged 16-25, citing a rate of 38 cases per million doses compared to 8 per million in other groups, based on a study published last year and new agency data....
FDA Expands COVID-19 Vaccine Warnings for Myocarditis Risk in Young Men
The FDA is expanding warning labels on Pfizer and Moderna's COVID-19 vaccines to include a higher risk of myocarditis and pericarditis in males aged 16-25, citing a rate of 38 cases per million doses compared to 8 per million in other groups, based on a study published last year and new agency data....
Progress
64% Bias Score
Personalized mRNA Vaccine Shows Promise Against Pancreatic Cancer
A small study shows a personalized mRNA vaccine may significantly improve pancreatic cancer survival rates by generating long-lasting T cells that target cancer cells; half the participants who had a strong immune response remained cancer-free for over three years, far exceeding typical survival rat...
Personalized mRNA Vaccine Shows Promise Against Pancreatic Cancer
A small study shows a personalized mRNA vaccine may significantly improve pancreatic cancer survival rates by generating long-lasting T cells that target cancer cells; half the participants who had a strong immune response remained cancer-free for over three years, far exceeding typical survival rat...
Progress
40% Bias Score
Showing 1 to 12 of 17 results